Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0112 | 0.3587 | 0.3341 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0051 | 0.1304 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0112 | 0.3587 | 0.3341 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0737 | 0.038 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0051 | 0.1304 | 0.1581 |
Loa Loa (eye worm) | cyclin C | 0.0089 | 0.2714 | 0.2434 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0036 | 0.0737 | 0.0621 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0737 | 0.0621 |
Toxoplasma gondii | exonuclease III APE | 0.0039 | 0.0875 | 0.6709 |
Brugia malayi | cell division control protein 2 homolog | 0.0051 | 0.1304 | 0.0969 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0139 | 0.4574 | 0.4365 |
Schistosoma mansoni | hypothetical protein | 0.0077 | 0.2268 | 0.3215 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0036 | 0.0737 | 0.038 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0737 | 0.0621 |
Brugia malayi | Protein kinase domain containing protein | 0.0051 | 0.1304 | 0.0969 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0039 | 0.0875 | 0.282 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0051 | 0.1304 | 0.1581 |
Loa Loa (eye worm) | CMGC/CDK/CDK7 protein kinase | 0.009 | 0.2769 | 0.2491 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0.1304 | 0.522 |
Echinococcus granulosus | cyclin dependent kinase | 0.0051 | 0.1304 | 0.1581 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0051 | 0.1304 | 1 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.0051 | 0.1304 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0051 | 0.1304 | 0.1581 |
Brugia malayi | cyclin-dependent kinase 7 homolog | 0.009 | 0.2769 | 0.2491 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0039 | 0.0875 | 0.5402 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0039 | 0.0875 | 0.5402 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0285 | 1 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0039 | 0.0875 | 0.282 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0051 | 0.1304 | 1 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.0051 | 0.1304 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0036 | 0.0737 | 0.038 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0051 | 0.1304 | 0.1581 |
Schistosoma mansoni | serine/threonine protein kinase | 0.009 | 0.2769 | 0.4064 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0051 | 0.1304 | 0.0969 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0039 | 0.0875 | 0.282 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0163 | 0.5455 | 0.528 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0051 | 0.1304 | 0.1581 |
Schistosoma mansoni | serine/threonine protein kinase | 0.009 | 0.2769 | 0.4064 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0039 | 0.0875 | 0.0524 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0039 | 0.0875 | 0.5 |
Schistosoma mansoni | ap endonuclease | 0.0039 | 0.0875 | 0.0854 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.2268 | 0.197 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0.1304 | 0.522 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0039 | 0.0875 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0737 | 0.0621 |
Echinococcus multilocularis | GPCR, family 2 | 0.0036 | 0.0737 | 0.0621 |
Echinococcus multilocularis | cyclin | 0.0089 | 0.2714 | 0.3971 |
Echinococcus multilocularis | oligomeric golgi complex subunit 3 | 0.0089 | 0.2714 | 0.3971 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0036 | 0.0737 | 0.0621 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0036 | 0.0737 | 0.038 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0077 | 0.2268 | 0.197 |
Giardia lamblia | Kinase, CMGC CDK | 0.0051 | 0.1304 | 1 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0051 | 0.1304 | 0.1581 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.0051 | 0.1304 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0039 | 0.0875 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0039 | 0.0875 | 0.5402 |
Echinococcus granulosus | GPCR family 2 | 0.0036 | 0.0737 | 0.0621 |
Plasmodium falciparum | protein kinase 5 | 0.0051 | 0.1304 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0036 | 0.0737 | 0.0621 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0039 | 0.0875 | 0.5 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0039 | 0.0875 | 0.0854 |
Echinococcus multilocularis | geminin | 0.0185 | 0.6273 | 1 |
Echinococcus granulosus | cyclin dependent kinase 7 | 0.009 | 0.2769 | 0.4064 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0051 | 0.1304 | 0.1581 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0051 | 0.1304 | 0.1581 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.0051 | 0.1304 | 1 |
Brugia malayi | Cyclin C | 0.0089 | 0.2714 | 0.2434 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0112 | 0.3587 | 0.3341 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0737 | 0.0621 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0.1304 | 0.522 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0039 | 0.0875 | 0.0524 |
Plasmodium vivax | protein kinase Crk2 | 0.0051 | 0.1304 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0039 | 0.0875 | 0.0854 |
Echinococcus granulosus | geminin | 0.0185 | 0.6273 | 1 |
Echinococcus granulosus | oligomeric golgi complex subunit 3 | 0.0089 | 0.2714 | 0.3971 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 0.6273 | 1 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0051 | 0.1304 | 0.1581 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0139 | 0.4574 | 0.4365 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0039 | 0.0875 | 0.5402 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1264 | 0.0928 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0051 | 0.1304 | 0.522 |
Schistosoma mansoni | g1/s-specific cyclin C | 0.0089 | 0.2714 | 0.3971 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0051 | 0.1304 | 0.0969 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0051 | 0.1304 | 0.522 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0051 | 0.1304 | 0.0969 |
Onchocerca volvulus | 0.0026 | 0.0371 | 0.5 | |
Giardia lamblia | Kinase, CMGC CDK | 0.0051 | 0.1304 | 1 |
Trichomonas vaginalis | cyclin H, putative | 0.0074 | 0.2159 | 1 |
Toxoplasma gondii | cell-cycle-associated protein kinase CDK, putative | 0.0051 | 0.1304 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 0.6273 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 7 | 0.009 | 0.2769 | 0.4064 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0163 | 0.5455 | 0.528 |
Echinococcus granulosus | cyclin | 0.0089 | 0.2714 | 0.3971 |
Entamoeba histolytica | hypothetical protein | 0.0074 | 0.2159 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.3587 | 0.3341 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0039 | 0.0875 | 0.5402 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0051 | 0.1304 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0039 | 0.0875 | 0.0854 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0036 | 0.0737 | 0.0621 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0039 | 0.0875 | 0.5402 |
Brugia malayi | MH2 domain containing protein | 0.0139 | 0.4574 | 0.4365 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.